DRONE VOLT - DRONE VOLT wins a tender from a major player in the European energy sector for a contract to provide pilot training services ...

SELECTIRENTE - 2025 annual results Strong performance and strengthened financial capacity to support the acquisition momentum already underway ...

THX Pharma (Theranexus), an innovative biopharmaceutical company focused on the treatment of rare neurological diseases, announces that it will host a live webinar on Tuesday, February 17 at 6:00 p.m.

The total number of shares that confers voting rights is 162,759,902. The total number of existing single voting rights is 102,021,598, the total number of existing double voting rights is 60,738,304, ...

Showroomprivé strengthen its governance: Appointment of two new independent and one non-independent board members Jany Gerometta and Laurence-Anne Parent join the Board of Directors of Showroomprivé ...

With its historical non-core activities exited, TRACTIAL can now fully concentrate on its mission: to build a Fintech-as-a-Service platform — regulated, interoperable, and designed to orchestrate the ...

Prodways Group recorded revenue of €15 million on a comparable basis in the fourth quarter of 2025, a slight decrease compared with the same period in 2024. The trends identified in previous quarters ...

Q4 and annual revenue growth; Gemini 3 Pro Deep Think audit of Artprice; The Art Market recovers with +12% turnover; AI set to dominate the Art Market in 2026 ...

ECONOCOM - 2025 full-year results - Solid performance despite a challenging environment and progress on the group's transformation as part of the One Econocom plan ...

Grenoble, February 10th, 2026 - Kalray (Euronext Growth Paris: ALKAL) provider of hardware and software technologies and solutions for intensive data processing from Cloud to Edge, announces the ...

Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...

In fourth-quarter 2025, against the backdrop of a contrasted global economic environment, DELFINGEN posted revenue of €89.6m, down 9.4%, including a strongly unfavourable currency effect of 5.0% ...